戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  a task that yields quantitative measures of body image.
2 nistered to enhance athletic performance and body image.
3 y in a distributed neural network underlying body image.
4 after radiotherapy, but with no detriment to body image.
5 ved in all psychosocial subscales except for body image.
6 nificant change scores were observed only in body image.
7  with relationships, sexual functioning, and body image.
8 tion but received mastectomy had the poorest body image.
9 eight, fear of gaining weight, and distorted body image.
10  disordered eating in relation to weight and body image.
11 argeting autoimmunity to correcting abnormal body image.
12 ctivity, healthy eating, and self-esteem and body image.
13  treatments that intervene to manipulate the body image.
14 h included quality of life, self-esteem, and body image.
15 bined with organ-based analysis of the whole-body images.
16 ar vertebrae in anterior and posterior whole-body images.
17 es were obtained; this was followed by whole-body images.
18 -410 MBq anti-(18)F-FACBC followed by static body images.
19 ms for quantitative, three-dimensional whole-body images.
20 pened animal confirmed the identity of whole-body images.
21 es, with a strong selectivity for individual body images.
22 e neurons responded to a small proportion of body images.
23 ate tissue well, IFPs are suitable for whole-body imaging.
24 or typical scan lengths at clinical head and body imaging.
25 regression of xenografts visualized by whole-body imaging.
26 alized directly by gamma-scintigraphic whole-body imaging.
27 ve of clinical studies, in particular, whole-body imaging.
28 kanamycin treatment were visualized by whole-body imaging.
29 er gavage was followed in real-time by whole-body imaging.
30  over a 10-day period as determined by whole-body imaging.
31 ity of the clinical PET/CT scanner for whole-body imaging.
32  tissues and cells and to non-invasive whole-body imaging.
33  unknown areas of disease when used for full-body imaging.
34 p radiolabelling allowed complementary whole-body imaging.
35  the question of how the brain constructs a 'body image.'
36 ical health (0.94), emotional health (0.94), body image (0.89), pain (0.92), planning (0.93), fatigue
37 fe satisfaction (11.65), appearance (11.40), body image (11.25), and pain (10.03).
38 e with acne, the highest-scored domains were body image (15.66), appearance (14.96), life satisfactio
39  who received breast conservation had better body image 2 years after treatment than women who had ma
40  of these technologic advances include whole-body imaging, 3-dimensional imaging, new scintillator ma
41 essive symptoms were associated with altered body image (35% of the variance, P < .001).
42 reflux (63%), eating restrictions (45%), and body image (44%), which persisted after PTG.
43  were a validated cosmesis (3-24 points) and body image (5-20 points) score after 3 and 12 months.
44 nctional scales, APR patients reported worse body image (70.3 vs 77.0, P = 0.0005) at 1 year than did
45 ance (11.05), itch (10.98), pain (9.97), and body image (8.75).
46 ences in tissue types in, for example, whole-body imaging, a set of tissue homogenates of different t
47                    The common distortions in body image across patient groups, despite differing SCI
48 nsgenic (luciferase) reporter mice and whole-body imaging, allowing noninvasive quantification of tra
49 ldren with pectus carinatum have a disturbed body image and a reduced quality of life.
50  more emphasis in society is placed on one's body image and appearance there has been an increase in
51 nal procedures and hospital admissions), and body image and cosmesis.
52  most domains of quality of life, as well as body image and depressive symptoms, within the first yea
53 sses characterized by marked disturbances in body image and eating patterns.
54 wn about the impact of surgical treatment on body image and health outcomes in older breast cancer pa
55 ntary explores the potential implications of body image and its distortions for the insurance hypothe
56 tion has the potential to improve a person's body image and quality of life but has important risks.
57 stectomy breast reconstruction is to restore body image and quality-of-life after mastectomy, but rem
58 pectus carinatum are at risk for a disturbed body image and reduced quality of life.
59 image in female breast cancer survivors, the Body Image and Relationships Scale (BIRS), was developed
60 tus (Breast Cancer Treatment Outcome Scale); body image and sexuality (Body Image Scale); and perceiv
61 treatment preferences predicts posttreatment body image and whether body image, in turn, affects ment
62                                        Whole-body images and spot views of the neck and chest were ob
63 cted in humans and model organisms including body images and whole-genome gene expression profiles.
64 ion of human tumor-host interaction by whole-body imaging and at the cellular level in fresh and froz
65 sualizes the tumor-host interaction by whole-body imaging and at the cellular level in fresh tissues,
66                                 Serial whole-body imaging and blood sampling were performed up to 24
67                                 Planar whole-body imaging and SPECT/CT were performed from thorax to
68 e to a neurologically determined disorder of body-image and bodyego induced by peripheral injury.
69 rted for the areas of family dysfunction and body image, and few studies have been published in the a
70 sychosocial mechanisms included self-esteem, body image, and friendship.
71                Sexual function, self-esteem, body image, and general health of female patients underg
72 ould be explained by changes in self-esteem, body image, and intrusive thoughts about the illness.
73  has salutary effects on sexual functioning, body image, and menopausal symptoms in BCSs with a sexua
74 , including symptoms, emotions, functioning, body image, and photosensitivity.
75 n and infection prevention, sexual function, body image, and romantic/sexual relationships.
76  (PCS), symptom resolution and satisfaction, body image, and sexual functioning, as well as other asp
77 on of the body external appearance, i.e. the body image, and suggest the existence of two functionall
78 two-photon microscopy and non-invasive whole-body imaging, and can be used to study microbial coloniz
79   Tumors are tracked in living mice by whole-body imaging, and macrometastases or micrometastases are
80 tectural affordances, we used a mobile brain/body imaging approach recording brain activity synchroni
81  mechanisms integrating sensory signals into body image are altered in subclinical and clinical EDs.
82                     Fully quantitative whole-body images are obtained for an axial extent of 100 cm i
83 chnological developments in mobile brain and body imaging are enabling new frontiers of real-world ne
84 findings highlight body image investment and body image as important psychological factors that may i
85  body mass index, body image investment, and body image as statistically significantly associated wit
86  a top-down approach using noninvasive whole-body imaging as a guide for in-depth characterization of
87 r Physical, Role and Social Functioning, and Body Image, as well as for Mobility, Self-care, and Pain
88 ble covalently bound product C3d by external body imaging, as a marker of complement activation in he
89                                    For whole-body imaging, as a measure of radiation exposure to the
90 ty of life (assessed via Short-Form 12), and body image (assessed with the Spanish Body Image Scale).
91 PECT/CT images were obtained after the whole-body images at 2 and 24 h if there was relevant uptake i
92                                        Whole-body images at this time showed only bladder, kidneys an
93 -MFBG intravenously followed by serial whole-body imaging at 0.5-1, 1-2, and 3-4 after injection.
94  but their limited diffusion precludes whole-body imaging at visceral sites.
95                                              Body image, avoidance coping, referral to the study by a
96 urse of treatment, noninvasive optical whole-body imaging based on brilliant red fluorescent protein
97 cantly better up to 24 months (P = .031) and body image better at 3, 24, and 36 months (P <= .01) for
98 tter physical functioning (P = .006), better body image (BI; P < .001), less pain (P < .001) and its
99 TV50)), SUV(max), SUV(mean), and other whole-body imaging biomarkers were calculated for each patient
100 etrosal sinus sampling, and adrenal or whole-body imaging can help identify tumor sources of hypercor
101 om involved organs is an obstacle that whole-body imaging can help overcome.
102                                        Whole-body imaging can provide information across lesions with
103 rders, psychosexual dysfunction and negative body image, collectively contributing to diminished heal
104 al-Axial, Spine, Hematologic Diseases, Whole-Body Imaging, Comparative Studies Supplemental material
105 SPLC-group showed superior mean cosmesis and body image compared with the 4PLC-group at 12-weeks (21
106 ients with ARVD/C had substantially elevated body image concerns (Florida Patient Acceptance Survey s
107              Data from 1165 young women with body image concerns (mean +/- SD age: 21.9 +/- 6.4 y) wh
108                          Breast symptoms and body image concerns reduced over time.
109 he FPAS showed that patients had significant body image concerns, but return to function and device-r
110 ure of support required from partners and in body image concerns.
111 al treatment of eating disorders and related body-image concerns in middle-aged and elderly women.
112                         Conduct disorder and body-image concerns represent important risk factors for
113 ation with AAS use, but conduct disorder and body-image concerns showed strong associations.
114    We hypothesized that conduct disorder and body-image concerns would be major risk factors for subs
115 l and psychological aspects of sexuality and body image, CSA was not a significant predictor of physi
116  thyroid carcinoma, and on radioiodine total-body imaging demonstrated focal, lower-right chest uptak
117                             Quality of life, body image, depressive symptoms, and marital adjustment
118                                            A body image discrepancy score was calculated from the dif
119 at clinicians should be alert for eating and body-image disorder even in women well beyond the younge
120                                              Body image dissatisfaction (BID) has been recognised as
121 ntral body fat deposition is associated with body image dissatisfaction and suggest that it may repre
122 ages has been linked to eating disorders and body image dissatisfaction in men, women, and children.
123                                              Body-image dissatisfaction in AN patients was not relate
124 be anhedonic, hunger and pain are muted, and body-image distortion obscures wasting, which together f
125 athology characterized by restricted eating, body image distortions and impaired socio-cognitive abil
126                                              Body image distortions are a core feature of anorexia ne
127                                              Body image distortions are common in healthy individuals
128  survivors experience clinically significant body image distress (BID), a psychosocial morbidity that
129                                  Research on body image distress suggests the importance of changes i
130  anxiety, fatigue and sleep, pain, pruritus, body image distress, sexual function, work disability, h
131                                              Body image disturbance (BID) is a core feature of eating
132                                     Although body image disturbance is considered one of the core cha
133 ry perceptual information that might sustain body image disturbance.
134 ed in psychiatric disorders characterised by body image disturbances (BIDs).
135 ), as increased levels of depersonalization, body image disturbances, and reduced sensitivity to phys
136 gly common in older women, as are associated body-image disturbances.
137 of self-esteem, attitudes toward male roles, body image, eating-related attitudes and behaviors, and
138 ention group reported greater improvement in body image (EST2 = .45; P = .009) and fewer menopausal s
139 te the feasibility of using mobile brain and body imaging even in very extreme conditions (race car d
140  use of avoidant coping strategies, negative body image, feelings of fear and uncertainty in relation
141      Four observers (experienced sonologist, body imaging fellow, 1st-year radiology resident, and pr
142 ed by radiology residents or board-certified body imaging fellows over a 12-month period.
143                           We used RIA, whole body imaging, flow cytometry, and fluorescence immunohis
144                    Systematic alterations in body image follow SCI although our results suggest these
145 times in the Patlak images than in the whole-body images for (68)Ga-DOTATOC and (68)Ga-DOTATATE, resp
146 art for 10 min, followed by sequential whole-body images for approximately 5 h.
147 the parametric Ki images compared with whole-body images for both (68)Ga-DOTATOC and (68)Ga DOTATATE.
148 ased with increasing scan rate, useful whole-body images for propranolol were obtained from the tissu
149 art for 10 min, followed by sequential whole-body imaging for 5 h.
150 hese results show the potential use of whole-body imaging for receptor status assessment, particularl
151            General psychosocial benefits and body image gains continued to manifest at 2 years postma
152                                              Body image improved, with slight changes at 6 months and
153                     A self-report measure of body image in female breast cancer survivors, the Body I
154 st a stronger influence of visual signals on body image in individuals with eating disorders (EDs) th
155 ining eating disorders, eating behavior, and body image in middle-aged and elderly women.
156             Introduced bacteria can be whole-body imaged in most mouse organs, including the peritone
157                                    PET whole body imaging in cancer provides the means to (i) identif
158             A method based on repeated whole-body imaging in combination with blood and urinary activ
159                                  Early whole-body imaging in conjunction with delayed whole-body scan
160 tic sensitivities of (123)I and (131)I whole-body imaging in differentiated thyroid cancer.
161 redicts posttreatment body image and whether body image, in turn, affects mental health in older wome
162 eralized estimating equations, we found that body image, in turn, predicted 2-year mental health.
163  recurrence support performing regular whole-body imaging initially every 6 to 12 months and continui
164 t, including sexual identity), their bodies (body image), initiating intimate and emotional relations
165 h cancer, aiming to improve sexual response, body image, intimacy and relationship issues, and overal
166                       Our findings highlight body image investment and body image as important psycho
167     Our analyses identified body mass index, body image investment, and body image as statistically s
168                                     How this body image is affected by changes in sensory inputs from
169 s of sexual satisfaction, orgasm and patient body image is essential, however, to allow a comparison
170                                              Body image is important for many older women, and receiv
171 se findings provide new insight into how the body image is maintained, and may prove useful in treatm
172 of their body, suggesting that the conscious body image is not fully determined by immediate sensory
173 sting revealed that the encoding capacity of body images is higher than that of characters, faces, an
174 valently used molecular imaging technique in body imaging is currently fluorine 18 fluorodeoxyglucose
175                     A key advantage of total-body imaging is that having all the organs in the field
176 l comorbidities, patients with HS often face body image issues and emotional distress that may increa
177 construction can restore quality of life and body image, its morbidity remains substantial.
178  with sex life, feeling sexually attractive, body image, marital satisfaction, quality of life, medic
179             In particular, we speculate that body image may be an intervening variable mediating the
180 , despite differing SCI levels, imply that a body image may be maintained despite chronic sensory and
181 relationship intimacy (primary outcomes) and body image, menopausal symptoms, marital functioning, ps
182 eighted Imaging, Radionuclide Therapy, Whole-Body Imaging, Metastases, Tumor Response, Treatment Effe
183 d therefore EUS is usually performed after a body imaging modality such as computed tomography or pos
184           (18)F-FDG PET is a molecular whole-body imaging modality that is increasingly being used fo
185 righter, red-shifted proteins can make whole-body imaging more sensitive owing to reduced absorption
186                                    For whole-body imaging, nude mice are very appropriate.
187                                        Whole body images of anesthetized mice taken at various time p
188 pendently analyzed all 7 reconstructed whole-body images of each patient.
189 omputed tomography allows quantitative whole-body imaging of (111)In-oxine-labeled CTLs at tumor site
190 ity and 45-cm axial field of view, for total-body imaging of (89)Zr-labeled antibodies in rhesus monk
191                                        Whole-body imaging of 12 patients, who received 111-185 MBq (3
192 ith the exception of liver metastases, whole-body imaging of ER expression with (18)F-FES PET can be
193 sed imaging technology can be used for whole-body imaging of fluorescent cells on essentially all org
194 taneous recurrence (TxN2bM0) underwent whole-body imaging of glucose metabolism with fluorodeoxygluco
195  to engineer mouse melanoma models for whole-body imaging of metastasis generated by human cells, cli
196 burden for future studies was based on whole-body imaging of monkeys.
197 n offers the potential for noninvasive whole-body imaging of numerous cellular and molecular processe
198 nts; demonstrated here is MALDI-IMS-MS whole body imaging of rats dosed at 6 mg/kg i.v. with an antic
199                                        Whole-body imaging of rhesus monkeys showed high uptake in kid
200                 It allows noninvasive, whole-body imaging of the FR.
201                            Noninvasive whole-body imaging of the immune status of individual patients
202                              Real-time whole-body imaging of the live animals confirmed improved tumo
203  objectives"), is used for three-color whole-body imaging of the two-color cancer cells interacting w
204 (PET) reporter genes allow noninvasive whole-body imaging of transplanted cells by detection with rad
205 dvantage of to develop a technology of whole-body imaging of tumors and gene expression in mouse inte
206     On many indices of disordered eating and body image, older women with eating disorder resemble yo
207 l and Social Function, Role Functioning, and Body Image on EORTC QLQ-C30/QLQ-CR38 analysis and Mobili
208                 All patients underwent whole-body imaging on a PET/CT device 1 h after (18)F-FDG inje
209                     Donors did not voice any body image or cosmetic concerns due to their scars.
210 uent to breast reconstruction (ie, effect on body image or psychosocial well-being).
211  increased by a factor of about 40 for total-body imaging or a factor of about 4-5 for imaging a sing
212    Healthy volunteers underwent serial whole-body imaging over an approximately 3-h interval, and org
213                                     On whole-body imaging, P-gp blockade significantly affected distr
214    The impact of SPLC on improving cosmesis, body image, pain, and QoL has not been evaluated in doub
215                                         Both body-image pathology and narrow stereotypic views of mas
216 and on previous observations suggesting that body-image pathology is associated with illicit use of a
217 re not found to be significant predictors of body image perception (p > 0.05).
218          In this study, the authors examined body image perception and body mass index (weight (kg)/h
219  difference between z-standardized values of body image perception and body mass index.
220 rences exist within racial groups concerning body image perception in relation to overweight status a
221                       As part of the survey, body image perception was determined in terms of body sh
222 individual patients to directly assess their body image perception.
223 ment, time since treatment, poor self esteem/body image, physical symptoms, poor performance status,
224 g superior short- and long-term cosmetic and body image, postoperative pain, and QoL in SPLC compared
225 g electronics to enable an inexpensive whole-body imaging probe.
226 ly after diagnosis; relationship, sexual, or body image problems after diagnosis; and coping strategi
227 d after diagnosis; relationship, sexual, and body image problems; coping strategies; and feelings of
228 hnique, PSMA PET represents a reliable whole-body imaging procedure in combination with second-line t
229 response than (18)F-FDG with favorable whole-body imaging properties.
230 ope distribution using (18)F-FDG and a whole-body imaging protocol to demonstrate proof-of-principle.
231 sttransplant, patient and team expectations, body image, psychiatric complications, functional goals
232 atients, including issues such as changes in body image, quality of life, anxiety, and guilt.
233  Metabolic Disorders, Volume Analysis, Whole-Body Imaging, Quantification, Supervised Learning, Convo
234 68)Ga-PSMA uptake was quantified using rigid-body image registration of (68)Ga-PSMA PET/CT and interv
235                                              Body image-related distress (BID) is common among head a
236                                        Whole-body imaging revealed that the cells retained their abil
237 nation and allogeneic graft rejection, whole body imaging reveals that RA signaling is temporally and
238 luation Subscale (AES) score (range, 1-5), a Body Image Satisfaction (BIS) score (range, 2-11), and r
239 Function Index, Rosenberg Self-Esteem scale, Body Image scale and SF-36, respectively.
240 ), and body image (assessed with the Spanish Body Image Scale).
241 nt Outcome Scale); body image and sexuality (Body Image Scale); and perceived risk of invasive breast
242 s Core 30 and Breast Cancer-Specific Module, Body Image Scale, protocol-specific items, and the Hospi
243 Depression Scale, and a summary scale of the Body Image Scale.
244                                              Body-image scale mean scores in the patients who had res
245 s of breast cancer, mental health score, and body image score.
246 ous flaps had significantly greater gains in body image scores (P = 0.003 and P = 0.034, respectively
247 sis identified 9 themes: Bonding/Attachment; Body Image; Self Esteem/Confidence; Female Role Models;
248 d data regarding the usefulness of brain and body imaging, serum and cerebrospinal fluid (CSF) studie
249 E) on menopausal symptoms (primary outcome), body image, sexual functioning, psychological well-being
250  to assess contentment with quality of life, body image, sexual satisfaction, breast cancer concern,
251                 In March 2003, self-referred body imaging (SRBI) centers were identified by using the
252 rk Skin versus the Short-Form-12, PVC Metra, Body Image States Scale, and Daily Life Quality Index as
253 an optimal combination for dual color, whole body imaging studies in model animals.
254 ed Imaging, Neural Networks, Oncology, Whole-Body Imaging, Supervised Learning, MR-Functional Imaging
255 hted MRI, Pediatric, Sarcoma, Staging, Whole-Body Imaging Supplemental material is available for this
256 t protein-transfected cancer cells and whole-body imaging system.
257 ositron emission tomography (PET) is a whole-body imaging technique using 18 fluorine-fluorodeoxygluc
258 n/Diagnosis, Lymphoma, Tumor Response, Whole-Body Imaging, Technology AssessmentClinical trial regist
259 reast radiotherapy was associated with worse body image than hypofractionated whole breast radiothera
260 st devised by the authors, the men chose the body image that they felt represented 1) their own body,
261 able (vaginal dryness, emotional well-being, body image, the quality of the partnered relationship, a
262 ification of PD-L1 through noninvasive whole-body imaging, thereby enhancing patient stratification.
263                           Here, we use whole-body imaging to determine the efficacy and kinetics of f
264 applications, enabling the noninvasive whole-body imaging to localize disease and identification of t
265 hy but was obvious on post-therapeutic whole-body imaging, underscoring the value of post-therapy ima
266                                              Body image was an important factor in treatment decision
267                                              Body image was measured using questions adapted from the
268                                        Whole-body imaging was carried out with either a trans-illumin
269  period of thyroid hormone withdrawal, whole-body imaging was performed approximately 24 and 72-96 h
270                                 Planar whole-body imaging was performed at 2 and 24 h after injection
271  on healthy volunteers, and sequential whole-body imaging was performed over 4 h.
272 8)F-FDG were administered and repeated whole-body imaging was performed.
273 and confocal microscopy, together with whole-body imaging, we measured tumor growth delay, survival r
274  CD4 T-cell precursor enumeration, and whole-body imaging, we report that DO affects the repertoire o
275                                        Whole-body images were acquired 30 min after injection of 5-15
276             For the first 22 patients, whole-body images were acquired at 15 min and at 1, 2, 3, and
277  biodistribution and dosimetry, serial whole-body images were acquired immediately after injection an
278                 Transmission scans and whole-body images were acquired sequentially on a dual-head ca
279                                        Whole-body images were obtained approximately 1 h after inject
280                                        Whole-body images were obtained at 10 min and 1, 2, 4, and 24
281 inistered as an intravenous bolus, and whole-body images were obtained at 30 min, 4 h, and (for the f
282                                        Whole-body images were obtained for each subject (mean +/- SD,
283                                        Whole-body images were obtained on these patients 7 d after 13
284 multaneous anterior and posterior view whole-body images were obtained under identical scan settings
285  Anterior and posterior spot views and whole-body images were obtained.
286          Using an iterative algorithm, whole-body images were reconstructed as transaxial, sagittal,
287 in brain and liver became visible, and whole-body images were recorded at video rates.
288                                    The whole-body images were used for real-time, quantitative measur
289                       In, for example, whole-body imaging where a diversity of tissue types are prese
290 esonance (MR) imaging and fluorescence whole body imaging, which respectively tracked iron oxide part
291 uclide bone scan, chest radiograph, or other body imaging, which was performed at the time of biochem
292      Forty patients underwent baseline whole-body imaging with 99mTc-sulfur colloid and evaluation of
293 f non-small cell lung cancer underwent whole-body imaging with a sequential trimodality PET/CT/MR sys
294 ng of oncologic malignancies underwent whole-body imaging with a sequential trimodality PET/CT/MR sys
295                                        Whole-body imaging with fluorescent proteins is a powerful tec
296                (18)F-FDG PET/CT scans (whole-body imaging with low-dose CT) of 24 consecutive patient
297 nd biological behavior of NIR-II dyes, whole body imaging with NIR-II dyes for cancer detection and s
298 imaging could provide both noninvasive whole-body imaging with organ-level biodistribution and fluore
299 study of 62Cu-PTSM was performed using whole-body imaging with PET in 10 healthy volunteers and with
300                                        Whole-body imaging, with scintimammography and PET, and newer

 
Page Top